Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration

  1. Hernandez-Pastor, L.J.
  2. Ortega, A.
  3. García-Layana, A.
  4. Giráldez, J.
Aldizkaria:
Graefe's Archive for Clinical and Experimental Ophthalmology

ISSN: 0721-832X

Argitalpen urtea: 2010

Alea: 248

Zenbakia: 4

Orrialdeak: 467-476

Mota: Artikulua

DOI: 10.1007/S00417-009-1156-9 GOOGLE SCHOLAR